A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical–chemical risk factors of cardiovascular disease in a primary care setting G.E. SchuitemakerG.A. van der PolG.J. Dinant Clinical Trials 16 February 2001 Pages: 857 - 863
An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers Z. ShamsiS. KimberI. Hindmarch Pharmacodynamics 06 February 2001 Pages: 865 - 871
Effects of fluvastatin on biliary lipids in subjects with an elevated cholesterol saturation index Mustafa Porsch-ÖzçürümezPhilip Daniel HardtHans-Ulrich Klör Pharmacodynamics 16 February 2001 Pages: 873 - 879
Cytochrome P 450 isoforms involved in melatonin metabolism in human liver microsomes Gabriella FaccioláMats HidestrandGunnel Tybring Pharmacokinetics and Disposition 01 February 2001 Pages: 881 - 888
Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919) S. Appel-DingemanseY. HirschbergJ. McLeod Pharmacokinetics and Disposition 03 February 2001 Pages: 889 - 891
Inhibitory effect of troglitazone on glucuronidation catalyzed by human uridine diphosphate-glucuronosyltransferase 1A6 Masaki ItoKazuo YamamotoTadao Bamba Pharmacokinetics and Disposition 01 February 2001 Pages: 893 - 895
Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults J. IsaacsohnM. ZinnyA.H. Heller Pharmacokinetics and Disposition 09 February 2001 Pages: 897 - 903
Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment Christian JoukhadarUrsula HerranzMarkus Müller Pharmacokinetics and Disposition 22 February 2001 Pages: 905 - 910
Initial uptake in use of sildenafil in general practice David WilliamsJohn Feely Pharmacoepidemiology and Prescription 01 February 2001 Pages: 911 - 914
Pharmacosurveillance and quality of care of thalassaemic patients R. ArborettiG. TognoniD. Alberti Pharmacoepidemiology and Prescription 09 February 2001 Pages: 915 - 922
Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study Jens-Ulrik RosholmMorten AndersenLars F. Gram Pharmacoepidemiology and Prescription 01 February 2001 Pages: 923 - 929
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? David GaistLuis Alberto García RodríguezSøren H. Sindrup Pharmacoepidemiology and Prescription 16 February 2001 Pages: 931 - 933
Analysis of the direct cost of adverse drug reactions in hospitalised patients R. BordetS. GautierJ. Caron Pharmacoepidemiology and Prescription 16 February 2001 Pages: 935 - 941
Seasonal variation of antibiotic and psycho-pharmacological drug prescriptions in a neuro-psychiatric hospital assessed by means of sine-wave models H. J. KochD. JostC. Raschka Letter to the Editors 16 February 2001 Pages: 943 - 945